Summary
This randomised controlled trial examined whether omega-3 fatty acid supplementation combined with isotretinoin treatment could favourably alter serum lipid metabolism in acne vulgaris patients compared to isotretinoin alone. Using liquid chromatography-tandem mass spectrometry, the authors identified 245 differential lipid metabolites following treatment and found strong correlation between specific lipid species (StE 20:5) and acne severity. The findings suggest potential metabolic pathways linking dyslipidaemia to acne pathogenesis and indicate isotretinoin-omega-3 combination therapy may restore lipid profiles closer to healthy controls.
Regional applicability
This study was conducted in China (Affiliated Hospital of Southwest Medical University) and is not directly UK-based; however, the findings on lipid metabolism in acne vulgaris and effects of omega-3 supplementation are biologically and clinically relevant to UK dermatological practice and may inform future clinical guidance on adjunctive treatments for severe acne, though local validation would strengthen applicability.
Key measures
Serum lipid metabolomics (LC-MS analysis), partial least squares discrimination analysis (PLS-DA), 245 differential metabolites identified, StE (20:5) levels, Global Acne Grading System score, Spearman correlation coefficients
Outcomes reported
The study measured serum lipid metabolomic differences between acne vulgaris patients and healthy controls, and investigated how isotretinoin combined with or without omega-3 supplementation altered serum lipid metabolism over 6 months. Differential lipid metabolites were identified and correlated with disease severity.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.